Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82


The high mobility group A1 gene: transforming inflammatory signals into cancer?

Resar LM.

Cancer Res. 2010 Jan 15;70(2):436-9. doi: 10.1158/0008-5472.CAN-09-1212. Epub 2010 Jan 12. Review.


HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.

Schuldenfrei A, Belton A, Kowalski J, Talbot CC Jr, Di Cello F, Poh W, Tsai HL, Shah SN, Huso TH, Huso DL, Resar LM.

BMC Genomics. 2011 Nov 4;12:549. doi: 10.1186/1471-2164-12-549.


High mobility group A1 and cancer: potential biomarker and therapeutic target.

Shah SN, Resar LM.

Histol Histopathol. 2012 May;27(5):567-79. doi: 10.14670/HH-27.567. Review.


The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Sumter TF, Xian L, Huso T, Koo M, Chang YT, Almasri TN, Chia L, Inglis C, Reid D, Resar LM.

Curr Mol Med. 2016;16(4):353-93. Review.


The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?

Hillion J, Dhara S, Sumter TF, Mukherjee M, Di Cello F, Belton A, Turkson J, Jaganathan S, Cheng L, Ye Z, Jove R, Aplan P, Lin YW, Wertzler K, Reeves R, Elbahlouh O, Kowalski J, Bhattacharya R, Resar LM.

Cancer Res. 2008 Dec 15;68(24):10121-7. doi: 10.1158/0008-5472.CAN-08-2121.


The high-mobility group A1 gene up-regulates cyclooxygenase 2 expression in uterine tumorigenesis.

Tesfaye A, Di Cello F, Hillion J, Ronnett BM, Elbahloul O, Ashfaq R, Dhara S, Prochownik E, Tworkoski K, Reeves R, Roden R, Ellenson LH, Huso DL, Resar LM.

Cancer Res. 2007 May 1;67(9):3998-4004.


Inactivation of the Cdkn2a locus cooperates with HMGA1 to drive T-cell leukemogenesis.

Di Cello F, Dhara S, Hristov AC, Kowalski J, Elbahloul O, Hillion J, Roy S, Meijerink JP, Winter SS, Larson RS, Huso DL, Resar L.

Leuk Lymphoma. 2013 Aug;54(8):1762-8. doi: 10.3109/10428194.2013.764422. Epub 2013 Feb 1.


Upregulation of MMP-2 by HMGA1 promotes transformation in undifferentiated, large-cell lung cancer.

Hillion J, Wood LJ, Mukherjee M, Bhattacharya R, Di Cello F, Kowalski J, Elbahloul O, Segal J, Poirier J, Rudin CM, Dhara S, Belton A, Joseph B, Zucker S, Resar LM.

Mol Cancer Res. 2009 Nov;7(11):1803-12. doi: 10.1158/1541-7786.MCR-08-0336. Epub 2009 Nov 10.


Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas.

Fedele M, Pentimalli F, Baldassarre G, Battista S, Klein-Szanto AJ, Kenyon L, Visone R, De Martino I, Ciarmiello A, Arra C, Viglietto G, Croce CM, Fusco A.

Oncogene. 2005 May 12;24(21):3427-35.


Transcriptional control of the human high mobility group A1 gene: basal and oncogenic Ras-regulated expression.

Cleynen I, Huysmans C, Sasazuki T, Shirasawa S, Van de Ven W, Peeters K.

Cancer Res. 2007 May 15;67(10):4620-9.


Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.

Dhar A, Hu J, Reeves R, Resar LM, Colburn NH.

Oncogene. 2004 May 27;23(25):4466-76.


The Wnt/β-catenin/T-cell factor 4 pathway up-regulates high-mobility group A1 expression in colon cancer.

Bush BM, Brock AT, Deng JA, Nelson RA, Sumter TF.

Cell Biochem Funct. 2013 Apr;31(3):228-36. doi: 10.1002/cbf.2876. Epub 2012 Sep 7.


High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.

Zhang Y, Ma T, Yang S, Xia M, Xu J, An H, Yang Y, Li S.

Mol Cell Biochem. 2011 Nov;357(1-2):363-71. doi: 10.1007/s11010-011-0907-1. Epub 2011 Jun 9.


High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene.

Esposito F, Tornincasa M, Chieffi P, De Martino I, Pierantoni GM, Fusco A.

Cancer Res. 2010 Jul 1;70(13):5379-88. doi: 10.1158/0008-5472.CAN-09-4199. Epub 2010 Jun 8.


The high mobility group A1 molecular switch: turning on cancer - can we turn it off?

Huso TH, Resar LM.

Expert Opin Ther Targets. 2014 May;18(5):541-53. doi: 10.1517/14728222.2014.900045. Epub 2014 Mar 31. Review.


The High Mobility Group A proteins contribute to thyroid cell transformation by regulating miR-603 and miR-10b expression.

Mussnich P, D'Angelo D, Leone V, Croce CM, Fusco A.

Mol Oncol. 2013 Jun;7(3):531-42. doi: 10.1016/j.molonc.2013.01.002. Epub 2013 Jan 17. Erratum in: Mol Oncol. 2014 Feb;8(1):159.


Overexpression of HMGA1 correlates with the malignant status and prognosis of breast cancer.

Huang R, Huang D, Dai W, Yang F.

Mol Cell Biochem. 2015 Jun;404(1-2):251-7. doi: 10.1007/s11010-015-2384-4. Epub 2015 Mar 13.


HMGA1 silencing restores normal stem cell characteristics in colon cancer stem cells by increasing p53 levels.

Puca F, Colamaio M, Federico A, Gemei M, Tosti N, Bastos AU, Del Vecchio L, Pece S, Battista S, Fusco A.

Oncotarget. 2014 May 30;5(10):3234-45.

Supplemental Content

Support Center